ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,527.72
      1.05%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Galapagos (GLPG)

      7. Galapagos (GLPG) News

      GLPG

      Galapagos (GLPG)

      Galapagos
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:GLPG
      DateTimeSourceHeadlineSymbolCompany
      07/19/201810:19AMDow Jones NewsNovartis: accord de licence avec Morphosys et Galapagos sur un traitement dermatologiqueEU:GLPGGalapagos
      07/19/20188:51AMDow Jones NewsNovartis, MorphoSys and Galapagos Shares Rise on News of DealEU:GLPGGalapagos
      07/19/20181:16AMGlobeNewswire Inc.MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Top Pharma PartnerEU:GLPGGalapagos
      07/09/20181:31AMGlobeNewswire Inc.Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPFEU:GLPGGalapagos
      06/26/20184:02PMGlobeNewswire Inc.Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patie...EU:GLPGGalapagos
      06/20/20184:02PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
      06/14/20184:02PMGlobeNewswire Inc.Transparency notificationEU:GLPGGalapagos
      05/30/20184:02PMGlobeNewswire Inc.GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PRO...EU:GLPGGalapagos
      05/20/20182:31PMGlobeNewswire Inc.GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATSEU:GLPGGalapagos
      05/01/20184:02PMGlobeNewswire Inc.Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patientsEU:GLPGGalapagos
      04/27/20181:31AMGlobeNewswire Inc.Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018EU:GLPGGalapagos
      04/25/20184:02PMGlobeNewswire Inc.Galapagos reports first quarter 2018 resultsEU:GLPGGalapagos
      04/24/20182:46AMGlobeNewswire Inc.Galapagos reports initiation of FALCON clinical trial in cystic fibrosisEU:GLPGGalapagos
      04/19/20184:02PMGlobeNewswire Inc.Galapagos creates new warrant planEU:GLPGGalapagos
      04/12/20184:02PMGlobeNewswire Inc.Galapagos announces ISABELA Phase 3 program in IPFEU:GLPGGalapagos
      03/23/20184:31PMGlobeNewswire Inc.Publication of the annual report and invitation to the annual shareholders' meetingEU:GLPGGalapagos
      03/20/20185:02PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
      02/22/20184:02PMGlobeNewswire Inc.Galapagos delivered in 2017EU:GLPGGalapagos
      02/22/20184:02PMGlobeNewswire Inc.Galapagos delivered in 2017EU:GLPGGalapagos
      02/17/20184:01AMGlobeNewswire Inc.Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at th...EU:GLPGGalapagos
      02/17/20184:01AMGlobeNewswire Inc.Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at th...EU:GLPGGalapagos
      01/08/201812:12PMDow Jones NewsL'EDITO: 2018 sera une nouvelle année de consolidation dans les biotechsEU:GLPGGalapagos
      01/08/20185:57AMDow Jones NewsM&A et partenariats devraient soutenir les biotechs en 2018 - Market BlogEU:GLPGGalapagos
      01/07/20184:01PMGlobeNewswire Inc.Positive topline results with GLPG1972 in osteoarthritis patientsEU:GLPGGalapagos
      01/07/20184:01PMGlobeNewswire Inc.Positive topline results with GLPG1972 in osteoarthritis patientsEU:GLPGGalapagos
      01/02/20184:02PMGlobeNewswire Inc.Update on progress in cystic fibrosis programsEU:GLPGGalapagos
      01/02/20184:02PMGlobeNewswire Inc.Update on progress in cystic fibrosis programsEU:GLPGGalapagos
      12/18/20171:31AMGlobeNewswire Inc.Transparency notificationEU:GLPGGalapagos
      12/18/20171:31AMGlobeNewswire Inc.Transparency notificationEU:GLPGGalapagos
      12/14/20174:02PMGlobeNewswire Inc.Galapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries...EU:GLPGGalapagos
       Showing the most relevant articles for your search:EU:GLPG

      Your Recent History

      BIT
      P210K9
      NLBNPIT210K9 20991231 12...
      BIT
      P1ZQT4
      NLBNPIT1ZQT4 20241220 600
      Delayed Upgrade Clock